Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.455 AUD 4.6% Market Closed
Updated: May 20, 2024

Immutep Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immutep Ltd
Income from Continuing Operations Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Immutep Ltd
ASX:IMM
Income from Continuing Operations
-AU$40.5m
CAGR 3-Years
-14%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Mesoblast Ltd
ASX:MSB
Income from Continuing Operations
-$73.1m
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Income from Continuing Operations
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
7%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Income from Continuing Operations
AU$30.2m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Income from Continuing Operations
AU$5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Income from Continuing Operations
-AU$21.7m
CAGR 3-Years
-20%
CAGR 5-Years
-35%
CAGR 10-Years
-23%

See Also

What is Immutep Ltd's Income from Continuing Operations?
Income from Continuing Operations
-40.5m AUD

Based on the financial report for Dec 31, 2023, Immutep Ltd's Income from Continuing Operations amounts to -40.5m AUD.

What is Immutep Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-12%

Over the last year, the Income from Continuing Operations growth was -11%. The average annual Income from Continuing Operations growth rates for Immutep Ltd have been -14% over the past three years , -19% over the past five years , and -12% over the past ten years .